Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso
- Resource Type
- Authors
- Fati Samadoulougou-Kirakoya; Toussaint Rouamba; Eli Rouamba; Zekiba Tarnagda; Biebo Bihoun; Hermann Sorgho; Seydou Nakanabo-Diallo; Paul Sondo; Karim Derra; Franco Pagnoni; Adama Kazienga; Halidou Tinto; Innocent Valea
- Source
- Drug Design, Development and Therapy, 14
Drug Design, Development and Therapy
- Subject
- Male
0301 basic medicine
Pharmaceutical Science
Abortion
Cohort Studies
Pharmacovigilance
0302 clinical medicine
Pregnancy
Drug Discovery
Prospective Studies
Child
Original Research
Sciences bio-médicales et agricoles
Artemisinins
Child, Preschool
030220 oncology & carcinogenesis
Drug Therapy, Combination
Female
pregnancy
Cohort study
safety
medicine.medical_specialty
Adolescent
malaria
Context (language use)
Antimalarials
Structure-Activity Relationship
03 medical and health sciences
artemisinin-based combination therapies
Burkina Faso
HDSS
medicine
Humans
Adverse effect
Pharmacology
Lumefantrine
Drug Design, Development and Therapy
Dose-Response Relationship, Drug
Proportional hazards model
business.industry
Infant, Newborn
Amodiaquine
Infant
medicine.disease
030104 developmental biology
Emergency medicine
Observational study
rural
business
Malaria
- Language
- ISSN
- 1177-8881
Resource-limited countries face challenges in setting up effective pharmacovigilance systems. This study aimed to monitor the occurrence of adverse events (AEs) after the use of artemisinin-based combination therapies (ACTs), identify potential drivers of reporting suspected adverse drug reactions (ADRs) and monitor AEs among women who were inadvertently exposed to ACTs in the first trimester of pregnancy.
info:eu-repo/semantics/published